Physiomics Share Discussion Threads

[spacedust] 05/6/2018 18:50

They are skinning stug alive. No more contracts are coming anytime soon.

Even if a 500k one comes along we will probably hit 8p to 10p and then every stugologist will start sucking each other off like they are wakners celebrating as if the share price is 32p

[smcl] 05/6/2018 18:10

Let’s be honest STUG/Stuck has a clear vested interest here- more than most. Also he has (a)‘fallen in love with this share’ and (b) he’s obviously not the brightest lamp in the street, olive short of a pizza etc.

Just my opinion - one of which we are all entitled!

[spacedust] 05/6/2018 16:41

So the disgracefulness continues.
Job for a friend to rinse more skin of stug punters

[myamay16] 05/6/2018 10:59

Post for Bio-simulation Scientist must have been filled.

Careers
We are not currently actively recruiting but are always interested to hear from experienced quantitative pharmacologists or biologists with a background in oncology. If this is you, please do contact us.

hxxp://www.physiomics-plc.com/about-us/careers/

[spacedust] 04/6/2018 18:07

Jim is the most cunning CEO I've come across. His name is him Cunningham from now on.

Remember he has huge confidence in the company and he shows this by selling a big chunk of his shares.

Disgraceful.

The founder is an outright wakner

[hms_trader] 04/6/2018 16:33

Ace Ventura, they didn't sell all their shares, they sold a portion Of The options they exercised, likely to cover taxes

[the stigologist] 04/6/2018 15:03

No wonder PYC want GROWTH CAPITAL to show such funders that they can access a variety of funding sources and partners to be a credible long term partner in R&D efforts

Also if Merck can go from spending 50k a year to 500k a year you'd expect bigger Pharmas to have capacity for that sort of spending as well if not more

If PYC continue to win with Big Pharma in Oncology Biosimulation/M&S market going forward I'd expect them to start impinging very seriously on Certara/Simulations Plus territory so accentuates the potential for either of those $850m and $300m companies looking to take PYC out to regain leadership position in such a key vertical as Oncology

[the stigologist] 04/6/2018 14:55

Wall of Money from Government and Wall of Money from Corporates

22 MAY 2018 | DARMSTADT, GERMANY

Reaching out to scientists all over the world with invitation to apply for research grants and to compete in research challenges

Funding of up to € 350,000 per research grant or up to € 30,000 per research challenge
Initiatives reflect anniversary theme: “Always Curious - Imagine the next 350 years”
Merck, a leading science and technology company, today announced several research grants and challenges during the company’s 350th anniversary year in addition to already existing initiatives. The new research grants and challenges are mainly directed to scientists working in institutes, universities or start-up companies around the world.

“The best innovation for patients and customers is generated when people from different disciplines or backgrounds work closely together. Therefore, we are constantly looking for new ways of connecting scientists, entrepreneurs and experts from various fields to find new solutions for today’s technological and scientific challenges,” said Isabel De Paoli, Chief Strategy Officer at Merck. “As a company that has been based on science and technology for 350 years, we not only think ahead at Merck but also engage with external researchers across the world to imagine the next 350 years in science and technology together.”

Merck aims to stimulate open innovation processes in the three areas of healthcare, life science and performance materials. Merck intends to provide several research grants of up to € 350,000 per year for three years in various research areas with the option of extension or expansion.

In detail, with the research grants the company is issuing a call to action in these fields:

Healthcare

o Next game-changing molecule or technology to help cure cancer or autoimmune disease

[myamay16] 04/6/2018 14:30

Merck KGAa Presenting new data from a number of high priority clinical development programs across its oncology portfolio at ASCO 2018 this week..

hxxps://www.merckgroup.com/en/news.html#businessUnit-business:corporate,newsType-ALL,year-ALL,month-ALL,page-0,filter-news.

[spacedust] 04/6/2018 13:19

Now 200k buys galore does nothing to share price That's what dilution does. Rinse to the oblivion. Milking cow machine.

[boxerdogz] 04/6/2018 12:54

Jim the cunning CEO of all time
Founder the wakner

Disgrace of a company LOLOLOL

[spacedust] 04/6/2018 11:41

Those 200k and 100k buys not doing Jack smidht to the share price Disgrace of a share

[spacedust] 04/6/2018 11:22

Disgrace or a company reissuing rns contract wins which theybhace been doing for decades.

Jim the cunning CEO of all time
Founder the wakner

Disgrace of a company

[davevt] 04/6/2018 11:05

That's nothing, there is a desperate self obsessed clueless psycho buys 2.9 percent of a company he has no apparent clue what it does and loses more and more each day posting on here all hours, and on twitter, and cross forums and thinks it's worth 100p. Bonkers eh

[howdlep] 04/6/2018 10:15

PWhite734,

Time for you to add to your short, albeit a very dangerous game after "the November 2017 frenzy"?

Or maybe wait for the lowest entry price you can get?
Nothing wrong with that.

Either way:-

1) Institutions or private investors will report when they cross a threshold.
2) The 4p placing is the only one since "the November 2017 frenzy" and "reflects a 60% premium to the price at which the Company last raised money in September 2016.
3) Institutions and private investors want to purchase shares at the lowest price possible. It is all about risk/reward. An institution taking shares at 4p provides them with the opportunity of multiple gains. To use your words, maybe they can foresee another "November 2017 frenzy"?

For someone (you) who has posted bearish comments about the stock for years, that has to be one of your daftest.

Let's see where the share price is in 6 months time. Perhaps you can post directly after the next "November 2017 freenzy"?

Best of luck with your investments.

----

PWhite734 Jun '18 - 02:29 - 3138 of 3138

myamay16 - "Plus, if new Institution is in at 3% or more should have RNS Mon or Tue."

Whether such an RNS appears is immaterial now. The last placing has set a new bench mark low since the November 2017 frenzy. Furthermore who wants an institution on your register who thinks the shares are only worth 4p when key mug punters think the shares should be priced at 100p.